|Articles|April 14, 2009

Coast Issued Warning Letter by FDA

To see FDA news on the warning letter the Agency has issued to coast, please click here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Trending on Applied Clinical Trials Online

Coast Issued Warning Letter by FDA

Related Content

From Study-by-Study to Portfolio Recruitment: Q&A with Gaynor Anders, Trialbee

Why Execution Strategy Begins at the Business Decision, Not Study Startup

ACT Brief: Sponsor Accountability in Outsourcing, Biomarker Strategy in Precision Oncology, and Novel Sciatica Therapy

Precision Oncology Trials Need to Reflect the Complexity of Cancer Biology

The Quiet Misconception Behind Most Clinical Execution Failures

Trending on Applied Clinical Trials Online

Patient Recruitment in Clinical Trials: Why the Industry's Longstanding Approach Is No Longer Fit for Purpose

Precision Oncology Trials Need to Reflect the Complexity of Cancer Biology

ACT Brief: Portfolio-Level Recruitment Strategy, Structural Change Through Systems Thinking, and Kidney Function Preservation in IgAN

ACT Brief: Local-First Communication Design, RBQM Financial Impact, and First Oral PCSK9 Inhibitor

The Quiet Misconception Behind Most Clinical Execution Failures